In conclusion, NFATc3 and VIP inextricably linked via a regulatory relationship in both COPD and IPF, supporting the concept that pathogenesis is mediated by NFATc3 and VIP may have a novel therapeutic role. Here, NFATC3 is linked to idiopathic pulmonary fibrosis.